Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer von Siena, S., Sartore-Bianchi, A., Marsoni, S., Hurwitz, H.I., McCall, S.J., Penault-Llorca, F., Srock, S., Bardelli, A., Trusolino, L.

Volltext

How liquid biopsies can change clinical practice in oncology von Siravegna, G., Mussolin, B., Venesio, T., Marsoni, S., Seoane, J., Dive, C., Papadopoulos, N., Kopetz, S., Corcoran, R.B., Siu, L.L., Bardelli, A.

Volltext

DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy von SINICROPE, Frank A, FOSTER, Nathan R, SARGENT, Daniel J, THIBODEAU, Stephen N, MARSONI, Silvia, MONGES, Genevieve, LABIANCA, Roberto, YOTHERS, Greg, ALLEGRA, Carmen, MOORE, Malcolm J, GALLINGER, Steven

Volltext

Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the ‘SENDO experience’ von Mandala`, M., Clerici, M., Corradino, I., Vitalini, C., Colombini, S., Torri, V., De Pascale, A., Marsoni, S.

Volltext

Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial von Rulli, E., Marabese, M., Torri, V., Farina, G., Veronese, S., Bettini, A., Longo, F., Moscetti, L., Ganzinelli, M., Lauricella, C., Copreni, E., Labianca, R., Martelli, O., Marsoni, S., Broggini, M., Garassino, M.C.

Volltext

Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort von Apicella, M, Migliore, C, Capelôa, T, Menegon, S, Cargnelutti, M, Degiuli, M, Sapino, A, Sottile, A, Sarotto, I, Casorzo, L, Cassoni, P, De Simone, M, Comoglio, P M, Marsoni, S, Corso, S, Giordano, S

Volltext

Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical Oncology von Leone, A.G., Miceli, R., Trapani, D., Massagrande, M., Morano, F., Marsoni, S., La Verde, N., Berardi, R., Casolino, R., Lambertini, M., Dalu, D., Di Maio, M., Beretta, G.D., Perrone, F., Cinieri, S., Pietrantonio, F.

Volltext

Combined anti-MET/EGFR treatment results in complete tumor regression and prevents resistance onset in a MET-amplified gastroesophageal xenopatient cohort von Giordano, S, Apicella, M, Migliore, C, Capeloa, T, Menegon, S, Cargnelutti, M, Sapino, A, Cassoni, P, Marsoni, S, Corso, S

Volltext

Actual developments in European regulatory and health technology assessment of new cancer drugs: what does this mean for oncology in Europe? von Bergmann, L., Enzmann, H., Broich, K., Hebborn, A., Marsoni, S., Goh, L., Smyth, J.F., Zwierzina, H.

Volltext

Outcome of patients with sarcoma and other mesenchymal tumours participating in phase I trials: a subset analysis of a European Phase I database von Cassier, P.A., Polivka, V., Judson, I., Soria, J.-C., Penel, N., Marsoni, S., Verweij, J., Schellens, J.H., Morales-Barrera, R., Schöffski, P., Voest, E.E., Gomez-Roca, C., Evans, T.R.J., Plummer, R., Gallerani, E., Kaye, S.B., Olmos, D.

Volltext

Efficacy of Adjuvant Fluorouracil and Folinic Acid in B2 Colon Cancer von International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators

Volltext

Prediction of early death among patients enrolled in phase I trials: development and validation of a new model based on platelet count and albumin von Ploquin, A, Olmos, D, Lacombe, D, A'Hern, R, Duhamel, A, Twelves, C, Marsoni, S, Morales-Barrera, R, Soria, J-C, Verweij, J, Voest, E E, Schöffski, P, Schellens, J H, Kramar, A, Kristeleit, R S, Arkenau, H-T, Kaye, S B, Penel, N

Volltext

Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours von Sessa, C, Cresta, S, Noberasco, C, Capri, G, Gallerani, E, Braud, F. De, Zucchetti, M, D’Incalci, M, Locatelli, A, Marsoni, S, Corradino, I, Minoia, C, Zintl, P, Gianni, L

Volltext

Phase I clinical study of the novel epothilone B analogue BMS-310705 given on a weekly schedule von Sessa, C, Perotti, A, Lladò, A, Cresta, S, Capri, G, Voi, M, Marsoni, S, Corradino, I, Gianni, L

Volltext

Venous thromboembolism is a relevant and underestimated adverse event in cancer patients treated in phase I studies von Mandalà, M, Grosso, F, Vitalini, C, Corradino, I, Sanfilippo, R, Colombini, S, Clerici, M, Labianca, R, De Pascale, A, Marsoni, S

Volltext

Molecular targeting: new therapeutic strategies to improve tumour apoptosis von Marsoni, S., Damia, G.

Volltext

Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials von Aabo, K, Adams, M, Adnitt, P, Alberts, DS, Athanazziou, A, Barley, V, Bell, DR, Bianchi, U, Bolis, G, Brady, MF, Brodovsky, HS, Bruckner, H, Buyse, M, Canetta, R, Chylak, V, Cohen, CJ, Colombo, N, Conte, PF, Crowther, D, Edmonson, JH, Gennatas, C, Gilbey, E, Gore, M, Guthrie, D, Kaye, SB, Laing, AH, Landoni, F, Leonard, RC, Lewis, C, Liu, PY, Mangioni, C, Marsoni, S, Meerpohl, H, Omura, GA, Parmar, MKB, Pater, J, Pecorelli, S, Presti, M, Sauerbrei, W, Skarlos, DV, Smalley, RV, Solomon, HJ, Stewart, LA, Sturgeon, JFG, Tattersall, MHN, Wharton, JT, ten Bokkel Huinink, WW, Tomirotti, M, Torri, W, Trope, C, Turbow, MM, Vermorken, JB, Webb, MJ, Wilbur, DW, Williams, CJ, Wiltshaw, E, Yeap, BY

Volltext

Randomized single‐agents trials in recurrent epithelial ovarian cancer von SESSA, C., MARSONI, S.

Volltext

Concerted escalation of dose and dosing duration in a phase I study of the oral camptothecin gimatecan (ST1481) in patients with advanced solid tumors von Sessa, C, Cresta, S, Cerny, T, Baselga, J, Rota Caremoli, E, Malossi, A, Hess, D, Trigo, J, Zucchetti, M, D'Incalci, M, Zaniboni, A, Capri, G, Gatti, B, Carminati, P, Zanna, C, Marsoni, S, Gianni, L

Volltext

ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer von The ICON Collaborators

Volltext